These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 9021441)

  • 1. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy.
    Kohno M; Minami M; Kano H; Yasunari K; Maeda K; Hanehira T; Yoshikawa J
    Metabolism; 2000 Oct; 49(10):1356-60. PubMed ID: 11079829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma levels of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension].
    Kosmala W; Spring A
    Pol Merkur Lekarski; 2003 Mar; 14(81):216-9. PubMed ID: 12914098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
    Soualmia H; Ayadi I; Omar S; Feki M; Drissa H; Mebazaa A; Kaabachi N
    Clin Lab; 2009; 55(3-4):120-7. PubMed ID: 19462934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
    Mark PB; Stewart GA; Gansevoort RT; Petrie CJ; McDonagh TA; Dargie HJ; Rodger RS; Jardine AG
    Nephrol Dial Transplant; 2006 Feb; 21(2):402-10. PubMed ID: 16221702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial natriuretic peptide, left ventricular mass and renin-angiotensin-aldosterone system in essential arterial hypertension of a mild or moderate degree].
    Gambini G; Talamonti D; Valori C
    G Ital Cardiol; 1992 Dec; 22(12):1397-403. PubMed ID: 1294423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril].
    Nogueira JB; Soares Ade O; da Costa JN
    Rev Port Cardiol; 1990 Jun; 9(6):511-6. PubMed ID: 2147377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.